2 healthcare stocks that could outperform the FTSE 100 index
Robert Stephens, CFA, discusses the outlook for AstraZeneca and Smith & Nephew.
2 years ago
Robert Stephens, CFA
Why Lloyds and Aviva could offer long-term income investing appeal
Robert Stephens, CFA, discusses the dividend potential of FTSE 100 shares Lloyds and Aviva.
2 years ago
Why high inflation and an uncertain economic outlook make Imperial Brands and Severn Trent more appealing
Robert Stephens, CFA, discusses the outlook for two defensive FTSE 350 stocks with growing dividends.
2 years ago
Why BAT and Unilever shares offer dividend investing appeal
Robert Stephens, CFA, discusses the prospects for two high-yielding FTSE 100 index shares.
2 years ago
2 FTSE 100 fallers with recovery potential
Robert Stephens, CFA, discusses the long-term prospects for two declining stocks.
2 years ago
Why WPP and LSE offer FTSE 100 outperformance potential after mixed recent returns
Robert Stephens, CFA, discusses the prospects for two FTSE 100 stocks that have produced very different return profiles over recent…
2 years ago
Why easyJet and IHG’s share prices may be undervalued
Robert Stephens, CFA, discusses the prospects for two travel and leisure stocks.
2 years ago
Can the Glencore and BHP share prices continue to outperform the FTSE 100?
Robert Stephens, CFA, discusses the outlook for BHP and Glencore.
2 years ago
Why these 2 falling property stocks offer value for money
Robert Stephens, CFA, discusses the outlook for two unpopular FTSE 350 property companies.
2 years ago
Why Tesco and Sainsbury’s share prices could offer investment appeal
Robert Stephens, CFA, discusses the outlook for Tesco and Sainsbury’s shares.
2 years ago